One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2018-99-117521
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 2 |
Affiliation: Dana-Farber Cancer Institute, Flinders Medical Centre, St James's University Hospital, Ospedale Niguarda Ca' Granda, Oncology Hematology Care, Columbia University Irving Medical Center, Semmelweis University, Peter MacCallum Cancer Centre, University of Ulm, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Verastem (United States), Medical University of ViennaThe Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL: Updated Results from the DUO Crossover Extension Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
